Next report date
Report period
Q1 2024
EPS estimate
−1.96MXN
Revenue estimate
46.75 MMXN
−516.35 MMXN
119.62 MMXN
51.89 M
Om PROQR THERAPEUTICS N V
Sektor
Bransch
VD
Daniel Anton de Boer
Webbplats
Huvudkvarter
Leiden
Employees (FY)
156
Grundat
2012
ISIN
NL0010872495
FIGI
BBG00PGGZYF2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
